TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹235 Cr | ₹101 Cr | ₹-142 Cr | ₹-300 Cr | ₹-422 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of TORRENT PHARMACEUTICALS ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2025 | ₹235 Cr |
Mar2024 | ₹101 Cr |
Mar2023 | ₹-142 Cr |
Mar2022 | ₹-300 Cr |
Mar2021 | ₹-422 Cr |
How is Deferred Tax Assets / Liabilities of TORRENT PHARMACEUTICALS Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹235 Cr | 132.43 | |
Mar2024 | ₹101 Cr | Positive | |
Mar2023 | ₹-142 Cr | Negative | |
Mar2022 | ₹-300 Cr | Negative | |
Mar2021 | ₹-422 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of TORRENT PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
TORRENT PHARMACEUTICALS | ₹121,150.6 Cr | NA | -0.9% | 4.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹386,197.0 Cr | 0.9% | -0.2% | -12.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,634.0 Cr | 0.1% | 0.4% | 16.6% | Stock Analytics | |
CIPLA | ₹126,082.0 Cr | 0.5% | 3.8% | -3.5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹108,783.0 Cr | 2.8% | 6.9% | -2% | Stock Analytics | |
MANKIND PHARMA | ₹107,183.0 Cr | 1.8% | 6.6% | 8.2% | Stock Analytics |
TORRENT PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
TORRENT PHARMACEUTICALS | NA |
-0.9% |
4.9% |
SENSEX | 1% |
2.1% |
0.5% |
You may also like the below Video Courses